FDA approval of new Alzheimer’s drug Aduhelm, developed in part by Brown researchers, mired in controversy
By Kathleen Meininger | July 20The Food and Drug Administration approved a new drug Aduhelm for the treatment of Alzheimer's disease June 7 through its accelerated approval pathway. While some patient advocacy groups and creators of the drug — including several University researchers — see the drug’s approval as a step forward, ...





















